VanEck Associates’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-30,274
| Closed | -$3.67M | – | 740 |
|
|
2017
Q2 | $3.67M | Buy |
30,274
+4,724
| +18% | +$572K | 0.02% | 319 |
|
|
2017
Q1 | $2.89M | Buy |
25,550
+2,161
| +9% | +$244K | 0.01% | 364 |
|
|
2016
Q4 | $2.54M | Sell |
23,389
-1,392
| -6% | -$151K | 0.01% | 373 |
|
|
2016
Q3 | $4.08M | Sell |
24,781
-6,165
| -20% | -$1.01M | 0.02% | 318 |
|
|
2016
Q2 | $4.42M | Sell |
30,946
-7,423
| -19% | -$1.06M | 0.02% | 286 |
|
|
2016
Q1 | $4.93M | Sell |
38,369
-7,359
| -16% | -$945K | 0.03% | 220 |
|
|
2015
Q4 | $6.83M | Buy |
45,728
+5,170
| +13% | +$772K | 0.05% | 207 |
|
|
2015
Q3 | $6.73M | Sell |
40,558
-13,201
| -25% | -$2.19M | 0.05% | 208 |
|
|
2015
Q2 | $13M | Buy |
53,759
+23,193
| +76% | +$5.6M | 0.08% | 189 |
|
|
2015
Q1 | $8.62M | Buy |
30,566
+1,816
| +6% | +$512K | 0.05% | 215 |
|
|
2014
Q4 | $4.49M | Sell |
28,750
-8,238
| -22% | -$1.29M | 0.03% | 272 |
|
|
2014
Q3 | $8.76M | Sell |
36,988
-419
| -1% | -$99.2K | 0.05% | 202 |
|
|
2014
Q2 | $8.85M | Buy |
37,407
+8,252
| +28% | +$1.95M | 0.04% | 208 |
|
|
2014
Q1 | $9.62M | Buy |
+29,155
| New | +$9.62M | 0.05% | 189 |
|